Lifeboat Foundation

Stethoscopes are among doctors’ most important instruments, yet there have not been any essential improvements to the device since the 1960s. Now, researchers at Aalto University have developed a device that analyzes a broad range of bodily functions and offers physicians a probable diagnosis as well as suggestions for appropriate further examinations. The researchers believe that the new device could eventually replace the stethoscope and enable quicker and more precise diagnoses.

A startup called Vital Signs is taking the device to the market. The researchers are currently testing the device in a clinical pilot trial. The intention is to launch the product to the most important European markets by the end of 2023.

“We have a well-functioning prototype, and the development path is clear,” says Alexis Kouros, the doctor leading the research team at Aalto.

PBS Member Stations rely on viewers like you. To support your local station, go to: http://to.pbs.org/DonateSPACE
↓ More info below ↓

Erratum: Figures in episode should be Minev et al. (2019), not Minney et al. (2009). Our apologies to the authors!

Continue reading “What Happens During a Quantum Jump?” »

Markets plunged on Friday, hope of taming the coronavirus dimmed and a new term entered the pandemic lexicon: Omicron.

The Covid-19 variant that emerged in South Africa was named after the 15th letter of the Greek alphabet.

The naming system, announced by the World Health Organization in May, makes public communication about variants easier and less confusing, the agency and experts said.

Pfizer is confident its COVID-19 antiviral pill, Paxlovid, will be effective against the new omicron variant, the drugmaker’s CEO told CNBC Nov. 29.

The omicron strain, first detected in South Africa, contains 32 mutations in the spike protein, and while preliminary evidence suggests the strain may increase the risk of reinfection, it’s still uncertain how the variant may affect illness severity or the effectiveness of vaccines and treatments.

Albert Bourla, PhD, Pfizer’s CEO, told CNBC the company’s antiviral was created with the spike protein in mind and expects it will work against omicron.

Nov 27 (Reuters) — The new Omicron coronavirus variant — identified first in South Africa, but also detected in Europe and Asia — is raising concern worldwide given the number of mutations, which might help it spread or even evade antibodies from prior infection or vaccination.

News of the variant prompted countries to announce new travel restrictions on Friday and sent drugmakers scrambling to see if their COVID-19 vaccines remain protective.

WHY ARE SCIENTISTS WORRIED?

Created by Wissam Tedros, RoDog is a reliable and hobby-level quadruped robot constructed out of accessible parts. The project implements a dozen RC servos actuators, measurement units such as a gyroscope, accelerometer, magnetometer, and unity for inertial measurement, an ESP32-CAM for streaming and WiFi connectivity, an OLED display, and more, all within a 3D-printed casing.

Entirely open source, Tedros’ post includes the BOM and all necessary files, as well as notes on mechanical design and assembly and data obtained from a MATLAB Simulink trial of the inverse kinematic control used with the embedded system. RoDog features a custom STM32F4 board for its brain, with the design available in full detail. The bot is quite compact at 20×10×5 cm, and the 12 motor controller board incorporates position and current feedback.

It is still in development 0, having gone through many iterations and tweaks, most of which are logged in the project files. However, its current form should perform well as a hobbyist’s robotic pet with room for add-ons.

Wireless implantable devices and IoT could manipulate the brains of animals from anywhere around the world due to their minimalistic hardware, low setup cost, ease of use, and customizable versatility.

A new study shows that researchers can remotely control the brain circuits of numerous animals simultaneously and independently through the internet. The scientists believe this newly developed technology can speed up brain research and various neuroscience studies to uncover basic brain functions as well as the underpinnings of various neuropsychiatric and neurological disorders.

A multidisciplinary team of researchers at KAIST, Washington University in St. Louis, and the University of Colorado, Boulder, created a wireless ecosystem with its own wireless implantable devices and Internet of Things (IoT) infrastructure to enable high-throughput neuroscience experiments over the internet. This innovative technology could enable scientists to manipulate the brains of animals from anywhere around the world. The study was published in the journal Nature Biomedical Engineering on November 25.

A new method of creating aerogels can produce up to 70 times more hydrogen than other means! This could help enable hydrogen power at greater scales.

Photonics is a branch of technology development that specializes in the creation of devices that can generate, detect or manipulate light. Recently, researchers at Université Paris-Saclay coined a new term for a new photonics sub-field called non-Euclidean photonics.

In a paper published in Physical Review Letters, the team introduced new devices that could be used as a test bed for non-Euclidean photonics. These devices are microlasers in which the laser cavity is a curved surface. In particular, they investigated one-sided, non-orientable surfaces known as Möbius strips.

“Our project started 10 years ago with the Ph.D. thesis of Clement Lafargue,” Melanie Lebental, one of the researchers who carried out the study, told Phys.org. “At the time, we had good expertise on 2D polymer-based microlasers and their use as quantum chaos platforms. We wanted to explore the third dimension, because we expected a lot of different features and a broad variety of dynamical behaviors, particularly regarding the symmetry classes of the laser modes and their polarization features.”